These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6288441

  • 21. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR, Forristal J, Beischel L.
    J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
    [Abstract] [Full Text] [Related]

  • 22. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T, Dodds AW, Law SK, Inoue K.
    Biochem J; 1989 Aug 01; 261(3):743-8. PubMed ID: 2803239
    [Abstract] [Full Text] [Related]

  • 23. Studies on the formation of a unique cellular intermediate (EAC14256) from EAC142 and C56.
    Kitamura H, Tsuboi M.
    Int Arch Allergy Appl Immunol; 1988 Aug 01; 85(3):322-8. PubMed ID: 3280504
    [Abstract] [Full Text] [Related]

  • 24. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM, Colomb MG.
    Eur J Immunol; 1986 Jun 01; 16(6):617-22. PubMed ID: 3487454
    [Abstract] [Full Text] [Related]

  • 25. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul 01; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

  • 26. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec 01; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

  • 27. Circulating immune complexes, complement factors C3, C4, C1-inhibitor, alpha-1-antitrypsin and immunoglobulins in asthmatic patients.
    Häfner GE, Wüthrich B, Grob PJ, Arrenbrecht S.
    Respiration; 1981 Dec 01; 41(4):248-57. PubMed ID: 6975491
    [Abstract] [Full Text] [Related]

  • 28. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
    Gronski P, Bodenbender L, Kanzy EJ, Piepenbrock M, Seiler FR.
    Immunobiology; 1986 Apr 01; 171(3):252-62. PubMed ID: 3011651
    [Abstract] [Full Text] [Related]

  • 29. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1978 May 01; 75(5):2416-20. PubMed ID: 276881
    [Abstract] [Full Text] [Related]

  • 30. Monoclonal anti-human C4b antibodies: stabilization and inhibition of the classical-pathway C3 convertase.
    Ichihara C, Nakamura T, Nagasawa S, Koyama J.
    Mol Immunol; 1986 Feb 01; 23(2):151-7. PubMed ID: 2422544
    [Abstract] [Full Text] [Related]

  • 31. Binding and activation of C4 and C3 on the red cell surface by non-complement enzymes.
    Kirschfink M, Borsos T.
    Mol Immunol; 1988 May 01; 25(5):505-12. PubMed ID: 3412332
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Concentration of complement C3 and C4 in sera containing monoclonal IgA or IgG].
    Bartelik S.
    Przegl Lek; 1990 May 01; 47(2):265-7. PubMed ID: 2356335
    [Abstract] [Full Text] [Related]

  • 34. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
    Vasei M, Monabbati A, Alizadeh-Naeeni M, Houshmand S, Azarpira N, Lankarani KB, Mosallaee M, Taghavi Sa, Geramizadeh B, Saberi-Firouzi M, Imaniyeh MH.
    Hepatogastroenterology; 2008 May 01; 55(84):1066-70. PubMed ID: 18705329
    [Abstract] [Full Text] [Related]

  • 35. An appraisal of third complement component (C3) and breakdown product (C3d) in erythema nodosum leprosum (ENL).
    Saha K, Chakraborty AK, Sharma V, Sehgal VN.
    Lepr Rev; 1982 Dec 01; 53(4):253-60. PubMed ID: 6984124
    [No Abstract] [Full Text] [Related]

  • 36. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.
    Kameyoshi Y, Matsushita M, Okada H.
    Immunology; 1989 Dec 01; 68(4):439-44. PubMed ID: 2481641
    [Abstract] [Full Text] [Related]

  • 37. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr 01; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 38. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    J Exp Med; 1981 Sep 01; 154(3):856-67. PubMed ID: 6912277
    [Abstract] [Full Text] [Related]

  • 39. Complement factors and acute phase reactants in the Guillain-Barré syndrome.
    Tönnessen TI, Nyland H, Aarli JA.
    Eur Neurol; 1982 Sep 01; 21(2):124-8. PubMed ID: 6920298
    [Abstract] [Full Text] [Related]

  • 40. Structure and function of membrane complement receptors. Summary.
    Ross GD.
    Fed Proc; 1982 Dec 01; 41(14):3089-93. PubMed ID: 6982833
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.